首页> 美国卫生研究院文献>other >The Major G-Quadruplex Formed in the Human Platelet-Derived Growth Factor Receptor β (PDGFR-β) Promoter Adopts a Novel Broken-Strand Structure in K+ Solution
【2h】

The Major G-Quadruplex Formed in the Human Platelet-Derived Growth Factor Receptor β (PDGFR-β) Promoter Adopts a Novel Broken-Strand Structure in K+ Solution

机译:在K +溶液中的主要G-四链在人血小板衍生生长因子受体β(pDGFR-β)形成促进剂采用一种新型断开的链结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Overexpression of PDGFR-β has been associated with cancers, vascular and fibrotic disorders. PDGFR-β has become an attractive target for the treatment of cancers and fibrotic disorders. DNA G-quadruplexes formed in GC-rich nuclease hypersensitivity element (NHE) of the human PDGFR-β gene promoter has been found to inhibit PDGFR-β transcriptional activity. Here we determined the major G-quadruplex formed in the PDGFR-β promoter. Instead of using the four continuous runs with three or more guanines, this G-quadruplex adopt a novel folding with a broken G-strand, to form a primarily parallel-stranded intramolecular structure with three 1-nt double-chain-reversal loops and one additional lateral loop. The novel folding of the PDGFR-β promoter G-quadruplex emphasizes the robustness of parallel-stranded structural motifs with a 1-nt loop. Together with recent progress on G-quadruplexes formed in gene promoter sequences, the 1-nt-looped GiNGj motif may be evolutionarily selected to serve as a stable foundation for the promoter G-quadruplexes to build upon. The novel folding of the PDGFR-β promoter G-quadruplex may represent an attractive target for small molecule drugs that specifically target this secondary structure and modulate PDGFR-β gene expression.
机译:PDGFR-β的过表达与癌症,血管和纤维化疾病有关。 PDGFR-β已成为治疗癌症和纤维变性疾病的有吸引力的靶标。已经发现在人PDGFR-β基因启动子的富含GC的核酸酶超敏元件(NHE)中形成的DNA G四联体抑制PDGFR-β转录活性。在这里,我们确定了在PDGFR-β启动子中形成的主要G-四链体。该G-四链体不是采用具有三个或更多鸟嘌呤的四个连续运行,而是采用新颖的折叠方式,具有断裂的G链,形成了具有三个1-nt双链反向环和一个的主要平行链分子内结构。额外的侧向循环。 PDGFR-β启动子G-四链体的新颖折叠强调了带有1 nt环的平行链结构基序的坚固性。连同在基因启动子序列中形成的G-四链体的最新进展一起,可以进化地选择1-nt-环GiNGj基序,以作为构建其上的启动子G-四链体的稳定基础。 PDGFR-β启动子G-四链体的新颖折叠可能代表小分子药物的诱人靶标,这些小分子药物特异性靶向该二级结构并调节PDGFR-β基因表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号